Literature DB >> 29106457

Rapid Loss of RNA Detection by In Situ Hybridization in Stored Tissue Blocks and Preservation by Cold Storage of Unstained Slides.

Javier A Baena-Del Valle1,2, Qizhi Zheng1, Jessica L Hicks1, Helen Fedor1, Bruce J Trock3,4,5, Colm Morrissey6, Eva Corey6, Toby C Cornish1,7, Karen S Sfanos1,3,4,5, Angelo M De Marzo1,3,4,5.   

Abstract

OBJECTIVES: Recent commercialization of methods for in situ hybridization using Z-pair probe/branched DNA amplification has led to increasing adoption of this technology for interrogating RNA expression in formalin-fixed, paraffin-embedded (FFPE) tissues. Current practice for FFPE block storage is to maintain them at room temperature, often for many years.
METHODS: To examine the effects of block storage time on FFPE tissues using a number of RNA in situ probes with the Advanced Cellular Diagnostic's RNAscope assay.
RESULTS: We report marked reductions in signals after 5 years and significant reductions often after 1 year. Furthermore, storing unstained slides cut from recent cases (<1 year old) at -20°C can preserve hybridization signals significantly better than storing the blocks at room temperature and cutting the slides fresh when needed.
CONCLUSIONS: We submit that the standard practice of storing FFPE tissue blocks at room temperature should be reevaluated to better preserve RNA for in situ hybridization. © American Society for Clinical Pathology, 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  Branched DNA amplification; Formalin-fixed; RNA in situ hybridization; paraffin-embedded tissues

Mesh:

Substances:

Year:  2017        PMID: 29106457      PMCID: PMC5848261          DOI: 10.1093/ajcp/aqx094

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  61 in total

1.  Long-term preservation of antigenicity on tissue microarrays.

Authors:  Kyle A DiVito; Lori A Charette; David L Rimm; Robert L Camp
Journal:  Lab Invest       Date:  2004-08       Impact factor: 5.662

2.  Effects of long-term storage on the detection of proteins, DNA, and mRNA in tissue microarray slides.

Authors:  Christina Karlsson; Mats G Karlsson
Journal:  J Histochem Cytochem       Date:  2011-12       Impact factor: 2.479

3.  Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma.

Authors:  S Zha; W R Gage; J Sauvageot; E A Saria; M J Putzi; C M Ewing; D A Faith; W G Nelson; A M De Marzo; W B Isaacs
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

4.  Bacterial Prostatitis Enhances 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine (PhIP)-Induced Cancer at Multiple Sites.

Authors:  Karen S Sfanos; Kirstie Canene-Adams; Heidi Hempel; Shu-Han Yu; Brian W Simons; Anthony J Schaeffer; Edward M Schaeffer; William G Nelson; Angelo M De Marzo
Journal:  Cancer Prev Res (Phila)       Date:  2015-05-19

5.  Single-copy gene detection using branched DNA (bDNA) in situ hybridization.

Authors:  A N Player; L P Shen; D Kenny; V P Antao; J A Kolberg
Journal:  J Histochem Cytochem       Date:  2001-05       Impact factor: 2.479

6.  Performance of a Branch Chain RNA In Situ Hybridization Assay for the Detection of High-risk Human Papillomavirus in Head and Neck Squamous Cell Carcinoma.

Authors:  Darcy A Kerr; Kshitij S Arora; Krishnan K Mahadevan; Jason L Hornick; Jeffrey F Krane; Miguel N Rivera; David T Ting; Vikram Deshpande; William C Faquin
Journal:  Am J Surg Pathol       Date:  2015-12       Impact factor: 6.394

7.  Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer.

Authors:  Bungo Furusato; Chun-Ling Gao; Lakshmi Ravindranath; Yongmei Chen; Jennifer Cullen; David G McLeod; Albert Dobi; Shiv Srivastava; Gyorgy Petrovics; Isabell A Sesterhenn
Journal:  Mod Pathol       Date:  2007-12-07       Impact factor: 7.842

Review 8.  Single-molecule fluorescence in situ hybridization: quantitative imaging of single RNA molecules.

Authors:  Sunjong Kwon
Journal:  BMB Rep       Date:  2013-02       Impact factor: 4.778

9.  In situ quantitative measurement of HER2mRNA predicts benefit from trastuzumab-containing chemotherapy in a cohort of metastatic breast cancer patients.

Authors:  Maria Vassilakopoulou; Taiwo Togun; Urania Dafni; Huan Cheng; Jennifer Bordeaux; Veronique M Neumeister; Mattheos Bobos; George Pentheroudakis; Dimosthenis V Skarlos; Dimitrios Pectasides; Vassiliki Kotoula; George Fountzilas; David L Rimm; Amanda Psyrri
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

10.  A Comparison of Fresh Frozen vs. Formalin-Fixed, Paraffin-Embedded Specimens of Canine Mammary Tumors via Branched-DNA Assay.

Authors:  Florenza Lüder Ripoli; Annika Mohr; Susanne Conradine Hammer; Saskia Willenbrock; Marion Hewicker-Trautwein; Silvia Hennecke; Hugo Murua Escobar; Ingo Nolte
Journal:  Int J Mol Sci       Date:  2016-05-13       Impact factor: 5.923

View more
  15 in total

1.  Mannose Receptor-positive Macrophage Infiltration Correlates with Prostate Cancer Onset and Metastatic Castration-resistant Disease.

Authors:  Jelani C Zarif; Javier A Baena-Del Valle; Jessica L Hicks; Christopher M Heaphy; Igor Vidal; Jacob Luo; Tamara L Lotan; Jody E Hooper; William B Isaacs; Kenneth J Pienta; Angelo M De Marzo
Journal:  Eur Urol Oncol       Date:  2018-10-19

2.  P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer.

Authors:  Janielle P Maynard; Jiayun Lu; Igor Vidal; Jessica Hicks; Luke Mummert; Tamirat Ali; Ryan Kempski; Ayanna M Carter; Rebecca Y Sosa; Lauren B Peiffer; Corinne E Joshu; Tamara L Lotan; Angelo M De Marzo; Karen S Sfanos
Journal:  J Pathol       Date:  2021-11-25       Impact factor: 7.996

3.  Modeling Human Prostate Cancer Metastasis in Mice via Resection of Subcutaneous Allografts.

Authors:  Lauren B Peiffer; Jessica Hicks; Rebecca Y Sosa; Angelo M De Marzo; Karen S Sfanos; Janielle P Maynard
Journal:  Front Oncol       Date:  2022-04-27       Impact factor: 5.738

4.  ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63.

Authors:  Alba Torres; Mohammed Alshalalfa; Elai Davicioni; Anuj Gupta; Srinivasan Yegnasubramanian; Sarah J Wheelan; Jonathan I Epstein; Angelo M De Marzo; Tamara L Lotan
Journal:  Prostate       Date:  2018-05-15       Impact factor: 4.104

Review 5.  Molecular Pathology of High-Grade Prostatic Intraepithelial Neoplasia: Challenges and Opportunities.

Authors:  Levent Trabzonlu; Ibrahim Kulac; Qizhi Zheng; Jessica L Hicks; Michael C Haffner; William G Nelson; Karen S Sfanos; Onur Ertunc; Tamara L Lotan; Christopher M Heaphy; Alan K Meeker; Srinivasan Yegnasubramanian; Angelo M De Marzo
Journal:  Cold Spring Harb Perspect Med       Date:  2019-04-01       Impact factor: 6.915

6.  AXL Is a Putative Tumor Suppressor and Dormancy Regulator in Prostate Cancer.

Authors:  Haley D Axelrod; Kenneth C Valkenburg; Sarah R Amend; Jessica L Hicks; Princy Parsana; Gonzalo Torga; Angelo M DeMarzo; Kenneth J Pienta
Journal:  Mol Cancer Res       Date:  2018-10-05       Impact factor: 5.852

7.  Guidelines for the Optimization and Validation of In Situ Hybridization.

Authors:  Julia Jones; William J Howat
Journal:  Methods Mol Biol       Date:  2020

8.  GSTP1 positive prostatic adenocarcinomas are more common in Black than White men in the United States.

Authors:  Igor Vidal; Qizhi Zheng; Jessica L Hicks; Jiayu Chen; Elizabeth A Platz; Bruce J Trock; Ibrahim Kulac; Javier A Baena-Del Valle; Karen S Sfanos; Sarah Ernst; Tracy Jones; Janielle P Maynard; Stephanie A Glavaris; William G Nelson; Srinivasan Yegnasubramanian; Angelo M De Marzo
Journal:  PLoS One       Date:  2021-06-30       Impact factor: 3.240

Review 9.  If this is true, what does it imply? How end-user antibody validation facilitates insights into biology and disease.

Authors:  Karen S Sfanos; Srinivasan Yegnasubramanian; William G Nelson; Tamara L Lotan; Ibrahim Kulac; Jessica L Hicks; Qizhi Zheng; Charles J Bieberich; Michael C Haffner; Angelo M De Marzo
Journal:  Asian J Urol       Date:  2018-12-12

10.  PTEN status assessment in the Johns Hopkins active surveillance cohort.

Authors:  Jeffrey J Tosoian; Liana B Guedes; Carlos L Morais; Mufaddal Mamawala; Ashley E Ross; Angelo M De Marzo; Bruce J Trock; Misop Han; H Ballentine Carter; Tamara L Lotan
Journal:  Prostate Cancer Prostatic Dis       Date:  2018-10-02       Impact factor: 5.554

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.